Author: Xu, Jimin; Shi, Pei-Yong; Li, Hongmin; Zhou, Jia
Title: Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential Cord-id: ju35nyir Document date: 2020_3_3
ID: ju35nyir
Snippet: [Image: see text] The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. In this brief review, we summarize the broad antiviral activity of
Document: [Image: see text] The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19.
Search related documents:
Co phrase search for related documents- action mode and addition time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- action mode and liver cancer: 1, 2
- action mode and lopinavir ritonavir: 1, 2, 3, 4
- action mode and low micromolar: 1, 2, 3, 4
- acute sars cov respiratory syndrome coronavirus and addition time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and addition time study: 1
- acute sars cov respiratory syndrome coronavirus and liver cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- acute sars cov respiratory syndrome coronavirus and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute sars cov respiratory syndrome coronavirus and low micromolar: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- acute sars cov respiratory syndrome coronavirus and low ph dependent: 1
- acute sars cov respiratory syndrome coronavirus and lymphoma cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute sars cov respiratory syndrome coronavirus and lymphoproliferative disorder: 1
- addition time and low micromolar: 1, 2, 3, 4, 5, 6
- addition time and low ph dependent: 1
- liver cancer and lymphoma cell: 1, 2, 3, 4
- lopinavir ritonavir and low micromolar: 1
- lopinavir ritonavir and lymphoma cell: 1, 2, 3
- lymphoma cell and lytic replication: 1
Co phrase search for related documents, hyperlinks ordered by date